A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging
ChemMedChem · 2026
DOI: 10.1002/cmdc.70450 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Kaixiang Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Fudan University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Boron Compounds, Fluorescent Dyes, Piperazines, Mouth Neoplasms. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Poly(ADP‐ribose) polymerase (PARP) is a clinically validated therapeutic target and an attractive biomarker for fluorescence‐guided tumor imaging. However, the nuclear localization of PARP imposes a stringent requirement on probe design, as fluorophore installation must not compromise nuclear entry of the targeting ligand. Herein, we report a focused series of 5‐azetidinyl BODIPY–olaparib conjugates as PARP‐targeted fluorescent probes. By attaching olaparib‐derived ligands to the 5‐position of the BODIPY core through flexible linkers, we sought to preserve conformational flexibility while introducing a donor–acceptor fluorophore with an enlarged Stokes shift. Among the synthesized probes, 1a exhibited the most favorable cellular imaging performance, showing efficient nuclear localization in PARP‐overexpressing U87 and Cal27 cells. Competitive blocking with olaparib and comparison with HEK293 cells supported PARP‐dependent imaging. In Cal27 xenograft and orthotopic oral tumor models, 1a showed rapid tumor accumulation and clear tumor visualization. It provides a wider range of probe options for intraoperative tracking of oral tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Fudan University, Shanghai, P. R. China.
ORCID-Profile: Xiaochun Dong, Weili Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, K., Qi, H., Dong, X., & Zhao, W. (2026). A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging. ChemMedChem. https://doi.org/10.1002/cmdc.70450
Vancouver
Yan K, Qi H, Dong X, Zhao W. A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging. ChemMedChem. 2026. doi:10.1002/cmdc.70450
BibTeX
@article{Yan2026,
author = {Yan, Kaixiang and Qi, Hengkai and Dong, Xiaochun and Zhao, Weili},
title = {A 5‐Azetidinyl BODIPY–Olaparib Conjugate for PARP‐Targeted Nuclear and Orthotopic Oral Tumor Imaging},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70450}
}
EUVIMED